share_log

Biomarin Pharmaceutical | 4: Statement of changes in beneficial ownership of securities-Director Slamon Dennis

SEC announcement ·  Mar 20 17:18
Disclaimer: This content is for informational and educational purposes only and does not constitute a recommendation or endorsement of any specific investment or investment strategy. Read more